The intricate interplay of immunosuppression and outcomes following Gram-negative bloodstream infection in solid organ transplantation.
作者信息
Mezochow Alyssa, Anesi Judith A
机构信息
Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
出版信息
Transpl Infect Dis. 2022 Dec;24(6):e13966. doi: 10.1111/tid.13966. Epub 2022 Nov 21.
Abstract
摘要
相似文献
1
The intricate interplay of immunosuppression and outcomes following Gram-negative bloodstream infection in solid organ transplantation.
Transpl Infect Dis. 2022 Dec;24(6):e13966. doi: 10.1111/tid.13966. Epub 2022 Nov 21.
2
Which trial do we need? Early oral antibiotic therapy for the treatment of gram-negative bloodstream infections.
Clin Microbiol Infect. 2023 Jun;29(6):670-672. doi: 10.1016/j.cmi.2023.02.012. Epub 2023 Feb 18.
3
Evaluation of extensively drug-resistant gram-negative bacteremia among solid-organ transplant recipients: a multicenter study.
Turk J Med Sci. 2021 Aug 30;51(4):1960-1968. doi: 10.3906/sag-2101-161.
4
Early transition to oral therapy in gram-negative bloodstream infections: what is the next step?
Clin Microbiol Infect. 2024 Apr;30(4):428-430. doi: 10.1016/j.cmi.2024.01.002. Epub 2024 Jan 10.
5
Gram-negative bacilli bacteremia: a 7 year retrospective study in a referral Brazilian tertiary-care teaching hospital.
J Med Microbiol. 2021 Jan;70(1). doi: 10.1099/jmm.0.001277.
6
Bloodstream infections in organ transplant recipients receiving alemtuzumab: no evidence of occurrence of organisms typically associated with profound T cell depletion.
J Infect. 2006 Oct;53(4):241-7. doi: 10.1016/j.jinf.2005.11.017. Epub 2006 Jan 3.
7
Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with Gram-negative bacteremia.
J Hosp Med. 2011 Sep;6(7):405-10. doi: 10.1002/jhm.899.
8
Multidrug-resistant Gram-negative bacterial infections in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Clin Transplant. 2019 Sep;33(9):e13594. doi: 10.1111/ctr.13594. Epub 2019 Jul 22.
9
A Decision Tree Using Patient Characteristics to Predict Resistance to Commonly Used Broad-Spectrum Antibiotics in Children With Gram-Negative Bloodstream Infections.
J Pediatric Infect Dis Soc. 2020 Apr 30;9(2):142-149. doi: 10.1093/jpids/piy137.
10
Impact of body mass index on clinical outcomes in patients with gram-negative bacteria bloodstream infections.
J Infect Chemother. 2016 Oct;22(10):671-6. doi: 10.1016/j.jiac.2016.07.006. Epub 2016 Aug 31.
引用本文的文献
1
Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study.
PLoS One. 2025 Jul 7;20(7):e0327535. doi: 10.1371/journal.pone.0327535. eCollection 2025.
2
Can the pan-immune-inflammation value predict gram negative bloodstream infection-related 30-day mortality in solid organ transplant patients?
BMC Infect Dis. 2024 May 24;24(1):526. doi: 10.1186/s12879-024-09413-x.
3
Real-time, random-access organ screening for carbapenem-resistant organisms (CRO) reduces CRO-associated, donor-derived infection mortality in lung transplant recipients.
Infection. 2024 Apr;52(2):403-412. doi: 10.1007/s15010-023-02089-6. Epub 2023 Aug 31.
本文引用的文献
1
Gram-negative bacteremia in solid organ transplant recipients: Clinical characteristics and outcomes as compared to immunocompetent non-transplant recipients.
Transpl Infect Dis. 2022 Dec;24(6):e13969. doi: 10.1111/tid.13969. Epub 2022 Nov 21.
2
Clinical Outcomes and Risk Factors for Carbapenem-resistant Enterobacterales Bloodstream Infection in Solid Organ Transplant Recipients.
Transplantation. 2023 Jan 1;107(1):254-263. doi: 10.1097/TP.0000000000004265. Epub 2022 Dec 8.
3
Bacteremia in solid organ transplant recipients as compared to immunocompetent patients: Acute phase cytokines and outcomes in a prospective, matched cohort study.
Am J Transplant. 2021 Jun;21(6):2113-2122. doi: 10.1111/ajt.16388. Epub 2020 Nov 20.
4
Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae among intensive care unit patients after orthotopic liver transplantation: risk factors for infection and impact of resistance on outcomes.
Transplant Proc. 2014 Nov;46(9):3216-8. doi: 10.1016/j.transproceed.2014.09.159.
5
Is bacteremic sepsis associated with higher mortality in transplant recipients than in nontransplant patients? A matched case-control propensity-adjusted study.
Clin Infect Dis. 2015 Jan 15;60(2):216-22. doi: 10.1093/cid/ciu789. Epub 2014 Oct 9.
6
The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.
Clin Infect Dis. 2014 May;58(9):1274-83. doi: 10.1093/cid/ciu052. Epub 2014 Jan 23.
7
Staphylococcus aureus bacteremia in solid organ transplant recipients: evidence for improved survival when compared with nontransplant patients.
Transplantation. 2012 May 27;93(10):1045-50. doi: 10.1097/TP.0b013e31824bf219.
8
Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.
J Clin Microbiol. 2010 May;48(5):1726-31. doi: 10.1128/JCM.02353-09. Epub 2010 Feb 24.
9
Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes.
Am J Infect Control. 1992 Oct;20(5):239-47. doi: 10.1016/s0196-6553(05)80197-x.
Zotero 插件